Ocular Therapeutix Inc (OCUL)
5.115
-0.74
(-12.56%)
USD |
NASDAQ |
Apr 19, 12:43
Ocular Therapeutix Profit Margin (Quarterly): -197.4% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -197.4% |
| September 30, 2023 | -3.42% |
| June 30, 2023 | -136.2% |
| March 31, 2023 | -226.7% |
| December 31, 2022 | -110.4% |
| September 30, 2022 | -202.2% |
| June 30, 2022 | -153.0% |
| March 31, 2022 | -95.11% |
| December 31, 2021 | -31.28% |
| September 30, 2021 | 21.86% |
| June 30, 2021 | -72.38% |
| March 31, 2021 | 42.51% |
| December 31, 2020 | -1.16K% |
| September 30, 2020 | -203.3% |
| June 30, 2020 | -2.33K% |
| March 31, 2020 | -824.5% |
| December 31, 2019 | -1.15K% |
| September 30, 2019 | -2.27K% |
| June 30, 2019 | -3.76K% |
| March 31, 2019 | -3.48K% |
| Date | Value |
|---|---|
| December 31, 2018 | -3.45K% |
| September 30, 2018 | -3.01K% |
| June 30, 2018 | -2.13K% |
| March 31, 2018 | -4.05K% |
| December 31, 2017 | -2.69K% |
| September 30, 2017 | -2.98K% |
| June 30, 2017 | -4.27K% |
| March 31, 2017 | -3.37K% |
| December 31, 2016 | -2.51K% |
| September 30, 2016 | -2.01K% |
| June 30, 2016 | -2.60K% |
| March 31, 2016 | -2.37K% |
| December 31, 2015 | -2.44K% |
| September 30, 2015 | -2.69K% |
| June 30, 2015 | -2.18K% |
| March 31, 2015 | -1.78K% |
| December 31, 2014 | -1.58K% |
| September 30, 2014 | -5.10K% |
| June 30, 2014 | -6.59K% |
| March 31, 2014 | -25.96K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.76K%
Minimum
Jun 2019
42.51%
Maximum
Mar 2021
-677.2%
Average
-197.4%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Assertio Holdings Inc | -174.0% |
| CytomX Therapeutics Inc | 3.15% |
| Regeneron Pharmaceuticals Inc | 33.77% |
| Cormedix Inc | -- |
| Verastem Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -274.3% |
| Return on Assets | -49.54% |
| Return on Invested Capital | -87.75% |
| Gross Profit Margin (Quarterly) | 90.64% |
| Operating Margin (Quarterly) | -135.5% |
| Return on Net Operating Assets | -178.8% |